Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10 USD | +3.14% | +5.21% | -41.32% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 1.55B |
---|---|---|---|---|---|
Net income 2024 * | -237M | Net income 2025 * | -271M | EV / Sales 2024 * | - |
Net cash position 2024 * | 478M | Net cash position 2025 * | 693M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-6.54
x | P/E ratio 2025 * |
-6.19
x | Employees | 120 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 71.92% |
Latest transcript on Neumora Therapeutics, Inc.
1 day | +3.30% | ||
1 week | +5.89% | ||
Current month | +1.72% | ||
1 month | +7.70% | ||
3 months | -42.06% | ||
6 months | -14.59% | ||
Current year | -40.94% |
Managers | Title | Age | Since |
---|---|---|---|
Carol Suh
FOU | Founder | 33 | 19-10-31 |
Henry Gosebruch
CEO | Chief Executive Officer | 51 | 23-07-17 |
Paul Berns
FOU | Founder | 57 | 19-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Paul Berns
FOU | Founder | 57 | 19-10-31 |
May Kin Ho
BRD | Director/Board Member | 71 | 21-03-31 |
Kristina Burow
BRD | Director/Board Member | 50 | 19-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-04 | 10 | +3.14% | 526 692 |
24-06-03 | 9.7 | -2.02% | 587,565 |
24-05-31 | 9.9 | +2.17% | 515,770 |
24-05-30 | 9.69 | +1.89% | 474,476 |
24-05-29 | 9.51 | 0.00% | 462,596 |
Delayed Quote Nasdaq, June 04, 2024 at 02:56 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-40.94% | 1.55B | |
+47.28% | 56.65B | |
-6.57% | 39.44B | |
+39.19% | 39.03B | |
-6.65% | 26.86B | |
+12.39% | 26.75B | |
-21.53% | 19.03B | |
+0.74% | 12.28B | |
+23.83% | 12.26B | |
+27.83% | 12.04B |
- Stock Market
- Equities
- NMRA Stock